Cleared Traditional

K221545 - MectaLIF Anterior Extension

K221545 is the FDA 510(k) clearance for MectaLIF Anterior Extension by Medacta International S.A.. It is a Class 2 Orthopedic device (product code OVD) cleared through the Traditional 510(k) pathway after a 150-day FDA review.

K221545 · Medacta International S.A. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2022
Decision
150d
Days
Class 2
Risk

K221545 is an FDA 510(k) clearance for the MectaLIF Anterior Extension. Classified as Intervertebral Fusion Device With Integrated Fixation, Lumbar (product code OVD), Class II - Special Controls.

Submitted by Medacta International S.A. (Castel San Pietro (Ch), CH). The FDA issued a Cleared decision on October 24, 2022 after a review of 150 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Medacta International S.A. devices

Submission Details

510(k) Number K221545 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 27, 2022
Decision Date October 24, 2022
Days to Decision 150 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
28d slower than avg
Panel avg: 122d · This submission: 150d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OVD Intervertebral Fusion Device With Integrated Fixation, Lumbar
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Lumbar Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft With Or Without Supplemental Fixation.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Medacta USA
Chris Lussier

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - OVD Intervertebral Fusion Device With Integrated Fixation, Lumbar

All 144
Devices cleared under the same product code (OVD) and FDA review panel - the closest regulatory comparables to K221545.
EVOLUTION SPINE Interbody System
K223146 · Evolution Spine · Feb 2023
EL CAPITAN Anterior Lumbar Interbody Fusion
K222554 · Astura Medical · Jan 2023
aprevo® anterior lumbar interbody fusion device with interfixation
K222009 · Carlsmed, Inc. · Nov 2022
NuVasive Cohere ALIF System Intervertebral Body Fusion Device
K221751 · Nu Vasive, Incorporated · Oct 2022
Standalone ALIF Interbody Fusion System
K221936 · Eminent Spine · Oct 2022
Southern Anterior Screw Fixated Cage (SASCA)
K221447 · Southern Medical (Pty) , Ltd. · Oct 2022